Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
91 Immunosuppressive Effect of Intrathecal Morphine, Dexmedetomidine, or Both in Combination with Bupivacaine on Patients Undergoing Major Abdominal Cancer Surgery Department of Anesthesia, Intensive care and Pain management Dr. Samar Muhammad mansour 2022
92 Differential regulation of CD45 expression on granulocytes, lymphocytes, and monocytes in COVID-19 Department of Anesthesia, Intensive care and Pain management Dr. Ahmed Hassan Othman Hassan 2022
93 Prognostic Outcome of Mesenchymal Transition Biomarkers in Correlation with EGFR Expression in Epithelial Ovarian Carcinoma Patients Department of Pathology Dr. Marwa Tammam Ameen Hammam 2022
94 Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2022
95 Pattern and Outcome of Neurological Complications During the Treatment of Pediatric Acute Leukemias in Upper Egypt Department of Pediatric Oncology Dr. Azaa Shibl Sayed Mahmoud 2022
96 Development of Sedative Dexmedetomidine Sublingual In Situ Gels: In Vitro and In Vivo Evaluations Department of Anesthesia, Intensive care and Pain management Dr. Neveen Abdelazeem Abdelraheem 2022
97 Pharmacokinetics and pharmacodynamics of 3 doses of oral-mucosal dexmedetomidine gel for sedative premedication in women undergoing modified radical mastectomy for breast cancer Department of Anesthesia, Intensive care and Pain management Dr. Fatma Adel Abd Diab. 2022
98 Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer Department of Clinical Pathology Dr. Dalia Osama Mohamed Ahmed 2022
99 Malnutrition Assessment in Pediatric Acute Lymphoblastic Leukemia in Upper Egypt and Its Effect on Induction Response Department of Pediatric Oncology Prof. Amany Mohamed Ali Ahmed 2022
100 Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2 Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2022